Inherited Disease
Seraseq® Cardiomyopathy Reference Material
Material Number
0740-0021
Size
1 x 200 µL
Inventory Status
In Stock
Unit
EA
Details
Resources
Specifications
Frequently Asked Questions
Seraseq Cardiomyopathy Reference Material addresses the lack of multiplexed, patient-like reference materials with an expert-designed product1 for targeted NGS assays focused on hypertrophic cardiomyopathy (HCM). This unique product combines ten actionable HCM mutations in a well-characterized genomic background and can be used for assay development, validation, and to support lab QC standardization.
Key features include:
- Ten variants considered pathogenic or likely pathogenic for HCM in a single sample
- Mutation targets precisely quantitated with digital PCR
- Well-characterized GM24385 human genomic DNA as background wild-type material
- Manufactured in cGMP compliant and ISO 13485-certified facilities
References:
1. Emily M Kudalkar, Naif AM Almontarishi, Catherine Huang, Bharathi Anekella, Mark Bowser, Elizabeth Hynes, Russell Garlick, Birgit H. Funke. Multiplexed reference materials as controls for diagnostic next generation sequencing – a pilot investigating applications for hypertrophic cardiomyopathy, The Journal of Molecular Diagnostics.
For research use only. Not for use in diagnostic procedures.
Seraseq Cardiomyopathy Reference Material Non-Requirement Letter
Doc type
Safety Data Sheet (Non-Requirement Letter)
Download
Cardiomyopathy Reference Material v1
Doc type
Product Sheet
Download
Seraseq Cardiomyopathy Reference Material
Doc type
Package Insert
Download
Seraseq Cardiomyopathy Reference Material
Seraseq Cardiomyopathy Reference Material
Seraseq Cardiomyopathy Reference Material
Mutations included in the Seraseq Cardiomyopathy Reference Material
Gene ID | Mutation Type | HGVS Nomenclature | Amino Acid Change | Class | Targe Allele Frequency |
MYBPC3 | Substitution | c.1504C>T | p.Arg502Trp | Pathogenic | 50% |
MYBPC3 | Small Insertion | c.2373_2374insG | p.Trp792ValfsX41 | Pathogenic | 50% |
MYBPC3 | Large Deletion (in repetitive region) | c.3628-41_3628-17del | NA | Likely Pathogenic | 50% |
MYH7 | Substitution | c.1988G>A | p.Arg663His | Pathogenic | 50% |
MYH7 | Substitution | c.1357C>T | p.Arg453Cys | Pathogenic | 50% |
MYH7 | Substitution | c.1750G>C | p.Gly584Arg | Likely Pathogenic | 50% |
TNNI3 | Small Deletion | c.532_534delAAG | p.Lys178del | Pathogenic | 50% |
TNNI3 | Substitution | c.575G>A | p.Arg192His | Pathogenic | 50% |
TNNT2 | Depletion (in highly repetitive region) | c.487_489delGAG | p.Glu163del | Pathogenic | 50% |
Inherited Disease FAQs
Review the common questions we receive from our customers and the responses we provide.